Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$683M |
| 2 |
Meta Platforms (Facebook)
META
|
+$553M |
| 3 |
RTX Corp
RTX
|
+$450M |
| 4 |
Eli Lilly
LLY
|
+$389M |
| 5 |
T-Mobile US
TMUS
|
+$386M |
Top Sells
| 1 |
Amazon
AMZN
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Gilead Sciences
GILD
|
+$467M |
| 4 |
Merck
MRK
|
+$368M |
| 5 |
Intel
INTC
|
+$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
ADT
ADT
$7.25B
| $3.78M | ﹤0.01% |
473,097
-387,142
| -45% | -$3.09M |
|
2052
Vericel Corp
VCEL
$1.62B
| $3.78M | ﹤0.01% |
273,145
-510,598
| -65% | -$7.06M |
|
2053
Prothena Corp
PRTA
$451M
| $3.77M | ﹤0.01% |
360,771
-151,535
| -30% | -$1.59M |
|
2054
Pilgrim's Pride
PPC
$10.3B
| $3.77M | ﹤0.01% |
223,050
+82,691
| +59% | +$1.4M |
|
2055
Madrigal Pharmaceuticals
MDGL
$9.63B
| $3.75M | ﹤0.01% |
33,131
-2,721
| -8% | -$308K |
|
2056
National Healthcare
NHC
$1.79B
| $3.75M | ﹤0.01% |
59,164
+3,725
| +7% | +$236K |
|
|
RPT
2057
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $3.75M | ﹤0.01% |
539,239
-910,142
| -63% | -$6.33M |
|
2058
Nelnet
NNI
$4.47B
| $3.74M | ﹤0.01% |
78,288
-44
| -0.1% | -$2.1K |
|
|
EFC
2059
Ellington Financial
EFC
$1.34B
| $3.73M | ﹤0.01% |
316,752
-81,217
| -20% | -$957K |
|
2060
Myriad Genetics
MYGN
$694M
| $3.73M | ﹤0.01% |
328,876
+30,677
| +10% | +$348K |
|
2061
Vitamin Cottage Natural Grocers
NGVC
$870M
| $3.72M | ﹤0.01% |
249,953
-49,137
| -16% | -$731K |
|
|
WDR
2062
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.68M | ﹤0.01% |
237,332
-12,834
| -5% | -$199K |
|
|
NREF
2063
NexPoint Real Estate Finance
NREF
$271M
| $3.67M | ﹤0.01% |
219,273
-111,432
| -34% | -$1.87M |
|
2064
Weis Markets
WMK
$1.76B
| $3.66M | ﹤0.01% |
73,002
+1,963
| +3% | +$98.4K |
|
2065
Seagate
STX
$41.5B
| $3.66M | ﹤0.01% |
75,532
+9,221
| +14% | +$446K |
|
|
SWTX
2066
DELISTED
SpringWorks Therapeutics
SWTX
| $3.66M | ﹤0.01% |
87,075
+44,333
| +104% | +$1.86M |
|
2067
iShares MSCI South Korea ETF
EWY
$5.52B
| $3.65M | ﹤0.01% |
63,917
-111,667
| -64% | -$6.38M |
|
|
DCPH
2068
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.64M | ﹤0.01% |
182,420
+77,103
| +73% | +$1.54M |
|
|
HEES
2069
DELISTED
H&E Equipment Services
HEES
| $3.64M | ﹤0.01% |
196,855
+155
| +0.1% | +$2.86K |
|
|
OIBR.C
2070
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $3.62M | ﹤0.01% |
3,451,191
+54,859
| +2% | +$57.6K |
|
2071
Winmark
WINA
$1.74B
| $3.62M | ﹤0.01% |
21,136
+8,124
| +62% | +$1.39M |
|
2072
National Research Corp
NRC
$369M
| $3.61M | ﹤0.01% |
62,016
+11,012
| +22% | +$641K |
|
2073
Groupon
GRPN
$935M
| $3.61M | ﹤0.01% |
199,028
-482,837
| -71% | -$8.75M |
|
2074
Usana Health Sciences
USNA
$557M
| $3.6M | ﹤0.01% |
48,956
-3,360
| -6% | -$247K |
|
2075
United Parks & Resorts
PRKS
$2.78B
| $3.59M | ﹤0.01% |
242,544
+13,155
| +6% | +$195K |
|